What are OnKure Therapeutics, Inc.'s total assets?

OnKure Therapeutics, Inc. (OKUR) holds $198.7M in total assets, up 98.9% year over year.

How much debt does OnKure Therapeutics, Inc. have?

OnKure Therapeutics, Inc. carries $409.0K in total debt against $184.4M of shareholders' equity, a debt-to-equity ratio of 0.00.

How much cash does OnKure Therapeutics, Inc. have?

OnKure Therapeutics, Inc. holds $192.1M in cash and equivalents.

Can OnKure Therapeutics, Inc. cover its short-term obligations?

Its current ratio is 13.78 — current assets exceed current liabilities.

Where does OnKure Therapeutics, Inc.'s balance sheet data come from?

Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

OnKure Therapeutics, Inc. OKUR Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$192.11M+225%	$59.05M-16.0%	$70.33M-15.6%	$83.37M-13.7%	$96.66M-12.7%
Prepaid expenses and other current assets	$9.54M+68.1%	$5.67M-7.4%	$6.13M+16.4%	$5.26M-2.6%	$5.4M+8.4%
Total current assets	$197.48M+225%	$60.84M-14.9%	$71.53M-15.4%	$84.55M-13.9%	$98.17M-13.1%
Property and equipment, net	$519K-16.0%	$618K-14.2%	$720K-12.3%	$821K-11.2%	$925K-9.8%
Operating lease right-of-use assets	$288K-25.6%	$387K-20.2%	$485K-16.5%	$581K-14.1%	$676K-12.2%
Other non-current assets	$405K+48.4%	$273K+163%	$104K-10.3%	$116K+6.4%	$109K0.0%
Total assets	$198.69M+220%	$62.12M-14.7%	$72.84M-15.4%	$86.07M-13.8%	$99.88M-13.1%
Accounts payable	$11.02M+669%	$1.43M+11.1%	$1.29M-45.8%	$2.38M+1.6%	$2.34M-21.0%
Operating lease liabilities, current	$409K-25.5%	$549K-3.2%	$567K+2.0%	$556K+1.8%	$546K+1.9%
Total current liabilities	$14.33M+142%	$5.92M-5.2%	$6.25M-17.8%	$7.6M-13.5%	$8.79M-16.6%
Operating Lease Liabilities (Total)	$409K-25.5%	$549K-20.1%	$687K-16.5%	$823K-13.8%	$955K-12.0%
Other non-current liabilities	$12K0.0%	$12K—	——	——	——
Total liabilities	$14.34M+142%	$5.93M-7.4%	$6.41M-18.9%	$7.9M-14.4%	$9.23M-16.7%
Common stock	——	——	——	——	——
Additional paid-in capital	$413.75M+53.0%	$270.42M+1.2%	$267.17M+1.1%	$264.2M+1.1%	$261.3M+1.1%
Retained earnings	-$229.4M-7.1%	-$214.24M-6.7%	-$200.74M-7.9%	-$186.04M-9.0%	-$170.65M-10.3%
Accumulated other comprehensive income (loss)	——	——	——	——	——
Total stockholders' equity	$184.35M+228%	$56.18M-15.4%	$66.43M-15.0%	$78.17M-13.8%	$90.65M-12.7%
Total liabilities and stockholders' equity	$198.69M+220%	$62.12M-14.7%	$72.84M-15.4%	$86.07M-13.8%	$99.88M-13.1%
Deferred Tax Assets and Other Non-Current Assets	$405K+48.4%	$273K+163%	$104K-10.3%	$116K+6.4%	$109K0.0%
Net Investment in Lease	$288K-25.6%	$387K-20.2%	$485K-16.5%	$581K-14.1%	$676K-12.2%
Operating lease right-of-use assets	$288K-25.6%	$387K-20.2%	$485K-16.5%	$581K-14.1%	$676K-12.2%
Other non-current assets	$405K+48.4%	$273K+163%	$104K-10.3%	$116K+6.4%	$109K0.0%
Operating Lease Right-of-Use Assets in Other Assets	$288K-25.6%	$387K-20.2%	$485K-16.5%	$581K-14.1%	$676K-12.2%
Software and Technology Licenses, Net	$405K+48.4%	$273K+163%	$104K-10.3%	$116K+6.4%	$109K0.0%
Accrued liabilities and other current	——	——	——	——	——
Deferred Compensation Liability (Non-Current)	——	——	——	——	——
Total debt	$409K-25.5%	$549K-20.1%	$687K-16.5%	$823K-13.8%	$955K-12.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are OnKure Therapeutics, Inc.'s total assets?: OnKure Therapeutics, Inc. (OKUR) holds $198.7M in total assets, up 98.9% year over year.
How much debt does OnKure Therapeutics, Inc. have?: OnKure Therapeutics, Inc. carries $409.0K in total debt against $184.4M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does OnKure Therapeutics, Inc. have?: OnKure Therapeutics, Inc. holds $192.1M in cash and equivalents.
Can OnKure Therapeutics, Inc. cover its short-term obligations?: Its current ratio is 13.78 — current assets exceed current liabilities.
Where does OnKure Therapeutics, Inc.'s balance sheet data come from?: Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.